Aquestive Therapeutics, Inc. Q4 2025 Earnings Call Summary – Moby Management characterizes the current period as a pivotal evolution with…
Read More

Aquestive Therapeutics, Inc. Q4 2025 Earnings Call Summary – Moby Management characterizes the current period as a pivotal evolution with…
Read More
Beyond Air, Inc. Q3 2026 Earnings Call Summary – Moby Revenue grew 105% year-over-year to $2.2 million, driven by expanded…
Read More